Foster City, CA, United States of America

Hui Tian

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Hui Tian: A Leader in Innovative Treatments for Metabolic and Neuroendocrine Disorders

Introduction

Hui Tian, based in Foster City, CA, is a prominent inventor known for his groundbreaking work in the fields of metabolic and neuroendocrine disorders. With an impressive portfolio of 18 patents, Tian has significantly contributed to the development of advanced therapeutic methods, particularly in treating conditions like obesity, diabetes, and various cancers.

Latest Patents

Among his latest patents, Hui Tian has developed methods of treating a wasting syndrome, increasing growth hormone levels, and enhancing GHSR activity with a LEAP2 antibody. These innovative binding agents are designed to modulate the interaction between liver-expressed antimicrobial peptide 2 (LEAP2) and the growth hormone secretagogue receptor (GHSR). His research provides new avenues for addressing neuroendocrine and metabolic diseases such as cachexia, anorexia, obesity, diabetes, acromegaly, gigantism, and Prader-Willi syndrome.

Additionally, Tian has patented methods for treating fibroblast growth factor 19-mediated cancers and tumors. These methods involve administering anti-IL-6 antibodies or inhibitors of the STAT3/JAK signaling pathway, demonstrating his commitment to finding effective treatments for serious health challenges.

Career Highlights

Throughout his career, Hui Tian has worked with leading biotechnology firms, including NGM Biopharmaceuticals, Inc. and Amgen Inc. His contributions in these organizations have facilitated significant advancements in drug development focused on treating complex diseases.

Collaborations

Hui Tian has collaborated with esteemed colleagues, including Lei Ling and Bei Shan. Together, they have contributed to the advancement of therapeutic technologies that are expected to have lasting impacts on patient care.

Conclusion

Hui Tian's innovative approaches and substantial patent portfolio underline his expertise in addressing challenging health conditions. His work continues to inspire advancements in therapeutic strategies, paving the way for new treatment methodologies that can significantly enhance patients' lives. With ongoing research and development efforts, Tian remains a pivotal figure in the realm of biotechnology and therapeutic innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…